Is an Alzheimer’s Vaccine on the Horizon?

The fight against Alzheimer’s disease remains one of medical science’s more demanding challenges. Progress has been slow and often frustrating, as one drug after another has failed to live up to its promise in human clinical trials. But those failures,… Continue reading

How Clinical Trials From Home Can Increase Access to Life-Changing Treatments

Some 85% of people over 60 use prescription drugs, according to the National Center for Health Statistics (NCHS). Yet, older people are not well represented in clinical trials, the gold standard for testing the safety and efficacy of medications, the N… Continue reading

How to Gain Access to Cancer Drugs Not Yet Approved by the FDA

In June 2019, the Food and Drug Administration (FDA) launched the federal government’s latest initiative to make it easier for Americans who have serious illnesses to gain access to experimental drugs. Dubbed Project Facilitate, it’s a call center that… Continue reading

‘Biomarkers of Resilience’ May Protect Us From Alzheimer’s

(Editor’s note: This article is part of an editorial partnership between Next Avenue and The American Federation for Aging Research, a national nonprofit organization whose mission is to support and advance healthy aging through biomedical research.) R… Continue reading

Dodging Dementia: More of Us Get at Least 12 Good, Happy Years After 65

(Editor’s note: This article originally was published by Kaiser Health News.) You’ve turned 65 and exited middle age. What are the chances you’ll develop cognitive impairment or dementia in the years ahead? New research about “cognitive life expectancy… Continue reading